Coombe Gary A 4
4 · PROCTER & GAMBLE Co · Filed Feb 13, 2026
Research Summary
AI-generated summary of this filing
Procter & Gamble CEO Gary Coombe Sells 36,093 Shares After Option Exercise
What Happened
Gary A. Coombe, CEO – Grooming at Procter & Gamble (PG), exercised stock options and immediately sold the resulting 36,093 shares on Feb 12, 2026. He paid $78.52 per share to exercise (cost ≈ $2,834,022) and sold the same 36,093 shares in the open market at a weighted average price of $162.33 for gross proceeds of about $5,859,002. The filing also shows a related derivative disposition entry tied to the exercise and a small earlier RSU-type grant from Nov 17, 2025.
Key Details
- Transaction date: 2026-02-12 (filed 2026-02-13 — timely filing).
- Exercise: 36,093 shares at $78.52 → $2,834,022 paid.
- Sale: 36,093 shares at weighted avg $162.33 → ~$5,859,002 proceeds (price range reported $162.33–$162.35).
- Related entries: a derivative disposition at $0 associated with the exercise; a prior grant (63.689 units) dated 2025-11-17 (derivative/RSU).
- Shares owned after the transaction: not specified in the provided filing summary — see the full Form 4 for exact post-transaction holdings.
- Footnotes: filing references dividend-equivalent RSUs and dividend reinvestment adjustments (see footnotes F1–F6 in the filing for details).
Context
- This was a cashless exercise: shares were acquired via exercise of a derivative (option/award) and the same shares were sold immediately in the open market. Such transactions commonly reflect routine liquidity or tax-withholding actions rather than a directional view on the stock.
- Derivative entries in the filing reflect the mechanics of exercising awards and settling related units; consult the full Form 4 for complete tax-withholding or retirement-delivery details.
Insider Transaction Report
Form 4
Coombe Gary A
CEO - Grooming
Transactions
- Exercise/Conversion
Common Stock
[F1][F2]2026-02-12$78.52/sh+36,093$2,834,022→ 71,086.789 total - Sale
Common Stock
[F3]2026-02-12$162.33/sh−36,093$5,859,002→ 34,993.789 total - Award
Restricted Stock Units
[F5][F6]2025-11-17+63.689→ 1,117.366 total→ Common Stock (63.689 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2026-02-12−36,093→ 36,093 totalExercise: $78.52From: 2021-02-26Exp: 2028-02-28→ Common Stock (36,093 underlying)
Holdings
- 486.434(indirect: By Trust)
Common Stock
[F4] - 1,295.35(indirect: International Stock Ownership Plan & Pension Plan (Switzerland))
Common Stock
Footnotes (6)
- [F1]Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.
- [F2]Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan.
- [F3]Weighted average price of the shares sold. The price range was $162.33 to $162.35. Full information regarding the number of shares sold at each separate price available upon request.
- [F4]Reflects adjustment to PST through December 31, 2025.
- [F5]Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
- [F6]These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.
Signature
/s/ Wednesday Shipp, attorney-in-fact for Gary A. Coombe|2026-02-13